Skip to search formSkip to main contentSkip to account menu

VIPR2 gene

Known as: VPAC2R, VIPR2, VIP and PACAP receptor 2 
National Institutes of Health

Related topics

Related topics

1 relation
Vasoactive Intestinal Peptide Receptors, Type II

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2006
Highly Cited
2006
Characterization of novel splice variants of the PAC1 receptor in human neuroblastoma cells: Consequences for signaling by VIP and PACAP
2005
2005
Analysis of the role of the PAC1 receptor in neutrophil recruitment, acute‐phase response, and nitric oxide production in septic shock
Infections caused by Gram‐negative bacteria constitute one of the major causes of septic shock, which results from the inability… 
Highly Cited
2004
Highly Cited
2004
Ageing and the Diurnal Expression of mRNAs for Vasoactive Intestinal Peptide and for the VPAC2 and PAC1 Receptors in the Suprachiasmatic Nucleus of Male Rats
Ageing alters fundamental aspects of circadian rhythmicity in mammals; the effects include reduced rhythm amplitude and… 
Highly Cited
2004
Highly Cited
2004
VIP and PACAP induce selective neuronal differentiation of mouse embryonic stem cells
The capacity of embryonic stem cells (ES cells) to differentiate into neuronal cells represents a potential source for neuronal… 
2004
2004
Evidence for the involvement of VPAC1 and VPAC2 receptors in pressure‐induced vasodilatation in rodents
A transient increase in skin blood flow in response to an innocuous local pressure application, defined as pressure‐induced… 
Highly Cited
2003
Highly Cited
2003
Roles of Vasoactive Intestinal Peptide (VIP) in the Expression of Different Immune Phenotypes by Wild-Type Mice and T Cell-Targeted Type II VIP Receptor Transgenic Mice1
Vasoactive intestinal peptide (VIP) and its two G protein-coupled receptors, VPAC1 and VPAC2, are quantitatively prominent and… 
Highly Cited
2002
Highly Cited
2002
A potent and highly selective VPAC2 agonist enhances glucose-induced insulin release and glucose disposal: a potential therapy for type 2 diabetes.
Pituitary adenylate cyclase-activating peptide (PACAP) and vasoactive intestinal peptide (VIP) activate two shared receptors… 
Review
2002
Review
2002
Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide
Highly Cited
2000
Highly Cited
2000
Identification of Key Residues for Interaction of Vasoactive Intestinal Peptide with Human VPAC1 and VPAC2Receptors and Development of a Highly Selective VPAC1Receptor Agonist
The widespread neuropeptide vasoactive intestinal peptide (VIP) has two receptors VPAC1 and VPAC2. Solid-phase syntheses of VIP… 
1999
1999
A Cloned Frog Vasoactive Intestinal Polypeptide/ Pituitary Adenylate Cyclase-Activating Polypeptide Receptor Exhibits Pharmacological and Tissue Distribution Characteristics of Both VPAC1 and VPAC2…
Three receptor subtypes for the neuropeptides vasoactive intestinal peptide (VIP) and pituitary adenylate cyclase-activating… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)